FDA warns healthcare providers to not use Wallcur IV solutions on patients

The U.S. Food and Drug Administration has alerted healthcare providers not to use Wallcur simulated intravenous products on any patients, as they are for training purposes only and their use can lead to adverse events.

Advertisement

According to the FDA, some Wallcur training IV products have been distributed to healthcare facilities and used on patients. The use of one such product in particular, Practi IV Solution Bags, has been associated with serious adverse events.

The FDA asks providers to report any incidents of use of Wallcur training IV products on patients to the MedWatch Adverse Event Reporting program. Find more information here.

More articles on patient safety:
CIO Dr. Pravene Nath: Combining patient safety with IT
CMS extends TB exposure compliance deadline for Providence Memorial in El Paso
10 most popular patient safety tools of 2014

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.